1-11 of 11
John Coombs
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Durable Responses and Improved Quality Of Life With Midostaurin (PKC412) In Advanced Systemic Mastocytosis (SM): Updated Stage 1 Results Of The Global D2201 Trial

Free
Jason Gotlib, MD, Hanneke C. Kluin-Nelemans, MD, PhD, Tracy I. George, MD, Cem Akin, MD, PhD, Karl Sotlar, MD, Olivier Hermine, Farrukh Awan, MD, MS, Elizabeth Hexner, MD, Michael Mauro, MD, Rodica Morariu, MD, Margaret Squier, MD, PhD, Matthieu Villeneuve, Fabienne Emery-Salbert, MSc, John Coombs, PharmD, MBA, Karin Hartmann, MD, Hans-Peter Horny, MD, Peter Valent, MD, Andreas Reiter, MD
Journal: Blood
Blood (2013) 122 (21): 106.
https://doi.org/10.1182/blood.V122.21.106.106
Published: 2013
Journal Articles

Assessment of Patient Reported Outcomes (PROs) From the Enestnd Trial with Minimum Follow-up of 36 Cycles.

Free
Jennifer L Beaumont, MS, Matthew Magestro, John Coombs, PharmD, MBA, Xiaolin Fan, PhD, Charisse Kemp, Roger J. Waltzman, MD
Journal: Blood
Blood (2012) 120 (21): 3166.
https://doi.org/10.1182/blood.V120.21.3166.3166
Published: 2012
Journal Articles

Does Baseline Health-Related Quality of Life or Symptom Burden Predict Clinical Outcomes in Patients with Newly Diagnosed CML-CP Treated with Nilotinib or Imatinib?

Free
Jennifer L Beaumont, MS, Cindy Nowinski, MD PhD, John Coombs, PharmD, MBA, Tomasz Szczudlo, Rick E. Blakesley, PhD, Neil J. Gallagher, MD, PhD, James Burns, MS, David Cella, PhD
Journal: Blood
Blood (2011) 118 (21): 1025.
https://doi.org/10.1182/blood.V118.21.1025.1025
Published: 2011
Journal Articles

Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response in Newly Diagnosed Chronic-phase cronic Myeloid Leukemia in Brasil: 24-months follow-up

Free
Marcia Dias Alves, MBA, John Coombs, PharmD, MBA, Jefferson Ruiz, MD, Joice Valentim, PhD, Marta M. Lemos, MD
Journal: Blood
Blood (2011) 118 (21): 4216.
https://doi.org/10.1182/blood.V118.21.4216.4216
Published: 2011
Journal Articles

Burden of Illness of Aggressive Systemic Mastocytosis (ASM)

Free
Michelle L Sotak, MPH, MBA, Mihaela Marin, MD, MSc, John Coombs, PharmD, MBA, April Teitelbaum, MD, MS
Journal: Blood
Blood (2011) 118 (21): 4755.
https://doi.org/10.1182/blood.V118.21.4755.4755
Published: 2011
Journal Articles

Burden of Illness of FLT-3 Mutated Acute Myeloid Leukemia (AML)

Free
Michelle L Sotak, MPH, MBA, Mihaela Marin, MD, MSc, John Coombs, PharmD, MBA, Gary J. Schiller, MD, April Teitelbaum, MD, MS
Journal: Blood
Blood (2011) 118 (21): 4765.
https://doi.org/10.1182/blood.V118.21.4765.4765
Published: 2011
Journal Articles

An Ethnographic Investigation Tracking the Experience of Chronic Myeloid Leukemia (CML) Patients on Tyrosine Kinase Inhibitor (TKI) Therapies

Free
François Guilhot, MD, John Coombs, PharmD, MBA, Tomasz Szczudlo, Oleg Zernovak, MD, Nancy J. Macdonald, PhD, Ari Shapiro, PhD
Journal: Blood
Blood (2010) 116 (21): 394.
https://doi.org/10.1182/blood.V116.21.394.394
Published: 2010
Journal Articles

Hospitalizations of Patients with Newly Diagnosed CML-CP Treated with Nilotinib or Imatinib: Results From a Randomized Phase III Trial

Free
Jennifer L Beaumont, MS*, John Coombs, PharmD, MBA*, amsi Bollu, V, PhD, MBA*, Richard C. Woodman, MD, David Cella, PhD*
Journal: Blood
Blood (2010) 116 (21): 3826.
https://doi.org/10.1182/blood.V116.21.3826.3826
Published: 2010
Journal Articles

A Global Retrospective and Physician-Based Analysis of Adherence to Tyrosine Kinase Inhibitor (TKI) Therapies for Chronic Myeloid Leukemia (CML).

Free
François Guilhot, MD, John Coombs, PharmD, MBA, Oleg Zernovak, MD, Tomasz Szczudlo, Gianantonio Rosti
Journal: Blood
Blood (2010) 116 (21): 1514.
https://doi.org/10.1182/blood.V116.21.1514.1514
Published: 2010
Journal Articles

Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response In Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia In Brazil

Free
Marcia Dias Alves, MBA, John Coombs, PharmD, MBA, Jefferson Ruiz, MD, Joice Valentim, PhD, Marta M. Lemos, MD
Journal: Blood
Blood (2010) 116 (21): 1520.
https://doi.org/10.1182/blood.V116.21.1520.1520
Published: 2010
Journal Articles

Predictors of Treatment Non-Adherence in Patients Treated with Imatinib Mesylate for Chronic Myeloid Leukemia.

Free
Meaghan StCharles, PhD, Vamsi K Bollu, PhD, MBA, Elizabeth Hornyak, BA, John Coombs, PharmD, MBA, Christopher M Blanchette, PhD, Daniel J. DeAngelo, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2209.
https://doi.org/10.1182/blood.V114.22.2209.2209
Published: 2009